These 50 medicines including Montelukast-Dikovin Plus failed the test, see the complete list

These 50 medicines including Montelukast-Dikovin Plus failed the test, see the complete list

The Central Drugs Standard Control Organization has failed the test of 50 medicines, including paracetamol. Out of 1280 samples of medicines that came to many labs in the country in October, 50 medicines failed the test. Come, here we tell you which medicines have failed the test. Instructions have been given to withdraw these medicines from the markets. Along with this, show-cause notices have also been issued to the companies making them.

See the list of medicines here
folic acid tablets ip
.sipdan-500
hexyplore
Airmol®-650 Tablets
Esolip 40
Cantop-40 Tablet
Omzole
Montek® LC
Levocetirizine Tablets IP
Palmagin-P
Markmox-500
Omkam
chromostat injection
pantop-dsr
Uriflo -D
misoprostol tablets
silodosin 4 mg
Diacovin-Plus Capsule
albendazole tablets ip 400 mg B
L – Methylfolate Tablets
Levetiracetam Tablet
metronidazole tablets
Tilvit (multivitamin infusion)
Otocap Capsule
Mycobal-Plus Capsule
Kingcath Tablet
Bcom-l
enalapril maleate
Pilogrel – A 75
Levocetirizine Dihydrochloride
RL 500 Injection (all of which are compound cidolym)
RL 500 Injection
RL 500 Injection
RL 500 Injection
RL 500 Injection
RL 500 Injection
RL 500 Injection
NS (Sodium Chloride)
Fenofibrate Tablets
Clariford-500
Ondasetron
Montelukast Tablets IP
bromhexine hydrochloride
nandrolone decanoate
pantoprazole sodium
RL 500 B Injection
midazolam injection
levocetirizi
Dicovin Plus
pilogrelam
is used as an antibiotic

Most of the drugs which have failed the test are used as antibiotics. Some drugs are also used for abdominal pain, headache, and fever. These medicines are also used for Vitamin D and in normal fever. Drug tests are conducted every month by the Central Drugs Standard Control Organisation. In the last few months also many medicines have failed these tests. Of the 50 medicines that failed on October, 11 were made only in Uttarakhand. Apart from this, there are many companies from Gujarat, Uttar Pradesh, Bihar, and Haryana. Many medicines made in Himachal Pradesh had failed in the test held recently.

Notice issued to companies

The Central Drugs Standard Control Organization has issued notices to these pharmaceutical companies seeking answers. An order has also been issued to withdraw the entire stock of all these 50 medicines from the market at the earliest. The assistant drug controllers of all these states have been asked to send a report on this matter at the earliest.

In this case, the IMA says that it is not known for what reason these medicines have failed, but it is necessary that the quality of the medicine remains 100 percent.